Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chloroquine-resistant malaria.

T E Wellems1, C V Plowe

  • 1Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. tew@helix.nih.gov

The Journal of Infectious Diseases
|August 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.

Science (New York, N.Y.)·2011
Same author

Association of HLA alleles with Plasmodium falciparum severity in Malian children.

Tissue antigens·2011
Same author

Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.

Parasite immunology·2009
Same author

Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance.

Clinical pharmacology and therapeutics·2007
Same author

[In vitro cultivation of fields isolates of Plasmodium falciparum in Mali].

Bulletin de la Societe de pathologie exotique (1990)·2007
Same author

P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same journal

Pharyngeal gonorrhea in Ugandan men with urogenital gonorrhea: differences in antimicrobial resistance and strain types between anatomical sites.

The Journal of infectious diseases·2026
Same journal

Proactive Surveillance of Public Swimming Pools to Prevent Delayed Detection of Cryptosporidiosis Outbreaks.

The Journal of infectious diseases·2026
Same journal

Diverse genetic lineages spreading across healthcare and community boundaries underlie extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) colonization burden in Botswana.

The Journal of infectious diseases·2026
Same journal

Retraction of: Tracking Plasmodium knowlesi Through Fecal DNA for Monitoring Zoonotic Transmission in Wild Macaques Across Southeast and South Asia.

The Journal of infectious diseases·2026
Same journal

Can malaria induce loss of vaccine immunity.

The Journal of infectious diseases·2026
Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026
See all related articles

Chloroquine resistance in malaria is driven by mutations in the PfCRT protein in P. falciparum. Field studies show resistance emerged multiple times and immunity impacts treatment outcomes.

Area of Science:

  • Malariology
  • Parasitology
  • Global Health

Background:

  • Chloroquine was a key antimalarial drug, but resistance evolved, impacting global public health.
  • Plasmodium falciparum, the deadliest malaria parasite, develops chloroquine resistance through mutations in the PfCRT protein.
  • PfCRT is likely a transporter in the parasite's digestive vacuole membrane.

Purpose of the Study:

  • To review field studies on PfCRT mutations and chloroquine resistance in malaria.
  • To understand the geographic origins and evolutionary patterns of chloroquine resistance.
  • To investigate the role of host immunity in chloroquine-resistant infections.

Main Methods:

  • Review of recent field studies on Plasmodium falciparum and Plasmodium vivax.
  • Analysis of data linking PfCRT mutations to chloroquine resistance.

Related Experiment Videos

  • Examination of the impact of host immunity on treatment outcomes.

    • Main Results:

    • PfCRT mutations are central to chloroquine resistance in P. falciparum.
    • Chloroquine resistance appears to have emerged independently in at least four geographic regions.
    • Host immunity significantly influences the outcome of chloroquine treatment in resistant infections.
    • Plasmodium vivax may have different chloroquine resistance mechanisms than P. falciparum.

    Conclusions:

    • PfCRT mutations are a critical factor in P. falciparum chloroquine resistance.
    • Understanding resistance evolution and immunity is vital for developing new antimalarial strategies.
    • Further research into resistance mechanisms and immunity will aid in replacing or improving chloroquine therapies.